Back
Nuveen Credit Strategies Income Fund Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
51
JQC
Nuveen Credit Strategies Income Fund
Last Price:
5.71
Seasonality Move:
-0.55%
Buy
51
LBPH
Longboard Pharmaceuticals
Last Price:
36.10
Seasonality Move:
-17.08%
Buy
51
Nuveen Credit Strategies Income Fund (JQC)
is a Buy
Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?
- The current Nuveen Credit Strategies Income Fund [JQC] share price is $5.72. The Score for JQC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- JQC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $36.22. The Score for LBPH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JQC Stock Price Chart
What is Nuveen Credit Strategies Income Fund's stock price today?
-
The Nuveen Credit Strategies Income Fund share price today is $5.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JQC is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $36.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
JQC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 49.27 | Sell |
Chaikin Money Flow: | 747777 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.68 - 5.84) | Sell |
Bollinger Bands (100): | (5.58 - 5.76) | Buy |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 57.18 | Buy |
Chaikin Money Flow: | -274481 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.33 - 35.83) | Buy |
Bollinger Bands (100): | (22.58 - 37.02) | Buy |
JQC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.72 | Buy |
20-day SMA: | 5.74 | Sell |
50-day SMA: | 5.72 | Buy |
200-day SMA: | 5.55 | Buy |
8-day EMA: | 5.71 | Buy |
20-day EMA: | 5.73 | Sell |
50-day EMA: | 5.71 | Buy |
200-day EMA: | 5.55 | Buy |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.21 | Buy |
20-day SMA: | 33.26 | Buy |
50-day SMA: | 34.3 | Buy |
200-day SMA: | 24.85 | Buy |
8-day EMA: | 34.89 | Buy |
20-day EMA: | 34.02 | Buy |
50-day EMA: | 33.21 | Buy |
200-day EMA: | 25.16 | Buy |
Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
Nuveen Credit Strategies Income Fund Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |